Insiders · SILO

Daniel E. Ryweck

Chief Financial Officer at Silo Pharma, Inc. (SILO)

Daniel E. Ryweck has filed 2 insider reports with the SEC since May 2023, as chief Financial Officer at Silo Pharma, Inc. (SILO). Daniel E. Ryweck made no open-market purchases or sales in the last 12 months. The latest filing, on May 27, 2025, reports grant or award at Silo Pharma, Inc. (SILO).

Filings
2
Companies
1
Bought on market
$2,126
Sold on market
None

Companies where Daniel E. Ryweck is an insider

CompanyRoleShares heldBoughtSoldAvg buyPrice nowLast filing
Silo Pharma, Inc. logo
SILO
Silo Pharma, Inc.
Chief Financial Officer5,000$2,126$2.13$1.84-14%May 27, 2025

Shares held: common shares owned directly after the latest filing that states it. Avg buy: open-market purchase dollars divided by shares bought, every filing on record. Price now: the latest daily close, against the average buy price.

Every filing

Compare Daniel E. Ryweck with

Other insiders at the same companies

Questions about Daniel E. Ryweck

What is Daniel E. Ryweck's role at Silo Pharma, Inc.?
Daniel E. Ryweck reports to the SEC as chief Financial Officer at Silo Pharma, Inc. (SILO), according to the latest filing on May 27, 2025.
How many shares does Daniel E. Ryweck own?
After the latest filing that states it, Daniel E. Ryweck directly owned 5,000 shares of Silo Pharma, Inc. (SILO). Shares held through trusts, funds or family members are reported separately and are not counted here.
Has Daniel E. Ryweck bought or sold stock recently?
The most recent open-market purchase was on May 26, 2023: bought 1,000 shares of Silo Pharma, Inc. (SILO) for $2,126 at an average of $2.13.
How do I get alerts when Daniel E. Ryweck files?
Follow Daniel E. Ryweck on Quantisnow and you get an email, and a phone notification on Plus, within minutes of each new Form 4 or Form 5, and of each Form 144 notice of a planned sale.

From SEC Forms 3, 4, 5 and 144 filed by Daniel E. Ryweck (SEC CIK 0001652799). Totals count each trade once, skipping amendments whose original is on file, from May 26, 2023 on. View on SEC EDGAR